You're contacting media contact of this press release

Title: CD BioSciences Fosters Biophysical Analysis Aimed at Biomedical Research

United States, 29th Jan 2024, King NewsWire - CD BioSciences is proud to announce its commitment to advancing biophysical analysis techniques for the purpose of enhancing biomedical research. The company's innovative biophysical analysis techniques and bioinformatics tools empower researchers to better understand the structure and function of macromolecules, organelles and cells, as well as experimental and computational methods for understanding biomedicine. Biophysical analysis plays a crucial role in biomedical research, bridging the gap between biology and physics to unravel the intricate mechanisms behind biological processes. By deciphering the physical properties and behavior of molecules, scientists can gain invaluable insights to identify new drug targets, optimize drug design, and improve therapeutic strategies. Recognizing the immense potential of biophysical analysis in expanding the frontiers of biomedical research, CD BioSciences has invested significantly in state-of-the-art technologies and a team of skilled experts. Equipped with cutting-edge instruments and extensive knowledge in structural biology, biophysics, and computational biology, CD BioSciences aims to revolutionize the field by offering a comprehensive suite of biophysical analysis services. CD BioSceinces’ biophysical services for biomedical research encompass a wide range of techniques, including but not limited to the analysis of iron-containing biomolecules, biophysical measurement of red blood cells, detection of insulin and glucagon, and in vivo imaging services. In addition, with its AFM technology platform, the company can provide high-resolution imaging and characterization services for various biomolecules including cells, organelles, proteins, DNA, biofilms, and bacte...

This press release is issued by King Newswire